journal article·2014-11

Adsorption at cell surface and cellular uptake of silica nanoparticles with different surface chemical functionalizations: impact on cytotoxicity

A. Kurtz-Chalot, J. P. Klein, J. Pourchez, D. Boudard, V. Bin, G. B. Alcantara, M. Martini, M. Cottier, V. Forest

Journal of Nanoparticle Research· Volume 16· Issue 11
Publisher page

Abstract

Silica nanoparticles are particularly interesting for medical applications because of the high inertness and chemical stability of silica material. However, at the nanoscale their innocuousness must be carefully verified before clinical use. The aim of this study was to investigate the in vitro biological toxicity of silica nanoparticles depending on their surface chemical functionalization. To that purpose, three kinds of 50 nm fluorescent silica-based nanoparticles were synthesized: (1) sterically stabilized silica nanoparticles coated with neutral polyethylene glycol molecules, (2) positively charged silica nanoparticles coated with amine groups, and (3) negatively charged silica nanoparticles coated with carboxylic acid groups. RAW 264.7 murine macrophages were incubated for 20 h with each kind of nanoparticles. Their cellular uptake and adsorption at the cell membrane were assessed by a fluorimetric assay, and cellular responses were evaluated in terms of cytotoxicity, pro-inflammatory factor production, and oxidative stress. Results showed that the highly positively charged nanoparticle were the most adsorbed at cell surface and triggered more cytotoxicity than other nanoparticle types. To conclude, this study clearly demonstrated that silica nanoparticles surface functionalization represents a key parameter in their cellular uptake and biological toxicity.
Source: expertdata · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. Albanese A, Tang PS, Chan WCW (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1–1610.1146/annurev-bioeng-071811-150124 ↗
2. Auffinger B, Morshed R, Tobias A, Cheng Y, Ahmed AU, Lesniak MS (2013) Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? Oncotarget 4:378–39610.18632/oncotarget.937 ↗
3. Benezra M, Penate-Medina O, Zanzonico PB, Schaer D, Ow H, Burns A, DeStanchina E, Longo V, Herz E, Iyer S et al (2011) Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J Clin Invest 121:2768–278010.1172/JCI45600 ↗
4. Bhattacharjee S, de Haan LHJ, Evers NM, Jiang X, Marcelis ATM, Zuilhof H, Rietjens IMCM, Alink GM (2010) Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells. Part Fibre Toxicol 7:2510.1186/1743-8977-7-25 ↗
5. Bruch J, Rehn S, Rehn B, Borm PJA, Fubini B (2004) Variation of biological responses to different respirable quartz flours determined by a vector model. Int J Hyg Environ Health 207:203–21610.1078/1438-4639-00278 ↗
6. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson KA, Linse S (2007) Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci 104:2050–205510.1073/pnas.0608582104 ↗
7. Chandolu V, Dass CR (2013) Treatment of lung cancer using nanoparticle drug delivery systems. Curr Drug Discov Technol 10:170–17610.2174/1570163811310020010 ↗
8. Chung T-H, Wu S-H, Yao M, Lu C-W, Lin Y-S, Hung Y, Mou C-Y, Chen Y-C, Huang D-M (2007) The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28:2959–296610.1016/j.biomaterials.2007.03.006 ↗
9. Colilla M, Manzano M, Vallet-Regí M (2008) Recent advances in ceramic implants as drug delivery systems for biomedical applications. Int J Nanomed 3:403–414
10. Dausend J, Musyanovych A, Dass M, Walther P, Schrezenmeier H, Landfester K, Mailänder V (2008) Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. Macromol Biosci 8:1135–114310.1002/mabi.200800123 ↗
11. Dell’Orco D, Lundqvist M, Oslakovic C, Cedervall T, Linse S (2010) Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS ONE 5:e1094910.1371/journal.pone.0010949 ↗
12. DeLoid G, Cohen JM, Darrah T, Derk R, Rojanasakul L, Pyrgiotakis G, Wohlleben W, Demokritou P (2014) Estimating the effective density of engineered nanomaterials for in vitro dosimetry. Nat Commun 5:351410.1038/ncomms4514 ↗
13. Duffin R, Mills NL, Donaldson K (2007) Nanoparticles-a thoracic toxicology perspective. Yonsei Med J 48:561–57210.3349/ymj.2007.48.4.561 ↗
14. El Badawy AM, Silva RG, Morris B, Scheckel KG, Suidan MT, Tolaymat TM (2011) Surface charge-dependent toxicity of silver nanoparticles. Environ Sci Technol 45:283–28710.1021/es1034188 ↗
15. Faunce TA, White J, Matthaei KI (2008) Integrated research into the nanoparticle-protein corona: a new focus for safe, sustainable and equitable development of nanomedicines. Nanomedicine 3:859–86610.2217/17435889.3.6.859 ↗
16. Frohlich E (2012) The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed 7:5577–559110.2147/IJN.S36111 ↗
17. Fubini B, Fenoglio I, Ceschino R, Ghiazza M, Martra G, Tomatis M, Borm P, Schins R, Bruch J (2004) Relationship between the state of the surface of four commercial quartz flours and their biological activity in vitro and in vivo. Int J Hyg Environ Health 207:89–10410.1078/1438-4639-00277 ↗
18. Ge Y, Zhang Y, Xia J, Ma M, He S, Nie F, Gu N (2009) Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro. Colloids Surf B 73:294–30110.1016/j.colsurfb.2009.05.031 ↗
19. Graf C, Gao Q, Schütz I, Noufele CN, Ruan W, Posselt U, Korotianskiy E, Nordmeyer D, Rancan F, Hadam S et al (2012) Surface functionalization of silica nanoparticles supports colloidal stability in physiological media and facilitates internalization in cells. Langmuir 28:7598–761310.1021/la204913t ↗
20. Gratton SEA, Ropp PA, Pohlhaus PD, Luft JC, Madden VJ, Napier ME, DeSimone JM (2008) The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 105:11613–1161810.1073/pnas.0801763105 ↗
21. Greish K, Thiagarajan G, Herd H, Price R, Bauer H, Hubbard D, Burckle A, Sadekar S, Yu T, Anwar A et al (2011) Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology 6:713–72310.3109/17435390.2011.604442 ↗
22. Guarnieri D, Malvindi MA, Belli V, Pompa PP, Netti P (2014) Effect of silica nanoparticles with variable size and surface functionalization on human endothelial cell viability and angiogenic activity. J Nanopart Res 16:1–1410.1007/s11051-013-2229-6 ↗
23. Hu Y, Xie J, Tong YW, Wang C-H (2007) Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells. J Controlled Release 118:7–1710.1016/j.jconrel.2006.11.028 ↗
24. Huang D-M, Hung Y, Ko B-S, Hsu S-C, Chen W-H, Chien C-L, Tsai C-P, Kuo C-T, Kang J-C, Yang C-S et al (2005) Highly efficient cellular labeling of mesoporous nanoparticles in human mesenchymal stem cells: implication for stem cell tracking. FASEB J 19:2014–201610.1096/fj.05-4288fje ↗
25. ISO TS/13014 (2012)—International Organization for Standardization—Nanotechnologies—Guidance on physico-chemical characterization of engineered nanoscale materials for toxicologic assessment. http://www.iso.org/iso/home/store/catalogue_tc/catalogue_detail.htm?csnumber=52334
26. Landsiedel R, Ma-Hock L, Hofmann T, Wiemann M, Strauss V, Treumann S, Wohlleben W, Gröters S, Wiench K, van Ravenzwaay B (2014) Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials. Part Fibre Toxicol 11:1610.1186/1743-8977-11-16 ↗
27. Lankoff A, Arabski M, Wegierek-Ciuk A, Kruszewski M, Lisowska H, Banasik-Nowak A, Rozga-Wijas K, Wojewodzka M, Slomkowski S (2013) Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro. Nanotoxicology 7:235–25010.3109/17435390.2011.649796 ↗
28. Leclerc L, Boudard D, Pourchez J, Forest V, Sabido O, Bin V, Palle S, Grosseau P, Bernache D, Cottier M (2010) Quantification of microsized fluorescent particles phagocytosis to a better knowledge of toxicity mechanisms. Inhal Toxicol 22:1091–110010.3109/08958378.2010.522781 ↗
29. Leclerc L, Boudard D, Pourchez J, Forest V, Marmuse L, Louis C, Bin V, Palle S, Grosseau P, Bernache-Assollant D et al (2012a) Quantitative cellular uptake of double fluorescent core-shelled model submicronic particles. J Nanopart Res 14:1–1310.1007/s11051-012-1221-x ↗
30. Leclerc L, Rima W, Boudard D, Pourchez J, Forest V, Bin V, Mowat P, Perriat P, Tillement O, Grosseau P et al (2012b) Size of submicrometric and nanometric particles affect cellular uptake and biological activity of macrophages in vitro. Inhal Toxicol 24:580–58810.3109/08958378.2012.699984 ↗
31. Lidén G (2011) The European commission tries to define nanomaterials. Ann Occup Hyg 55:1–510.1093/annhyg/meq092 ↗
32. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA (2008) Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. PNAS 105:14265–1427010.1073/pnas.0805135105 ↗
33. Luzio JP, Poupon V, Lindsay MR, Mullock BM, Piper RC, Pryor PR (2003) Membrane dynamics and the biogenesis of lysosomes. Mol Membr Biol 20:141–15410.1080/0968768031000089546 ↗
34. Martini M, Perriat P, Montagna M, Pansu R, Julien C, Tillement O, Roux S (2009) How gold particles suppress concentration quenching of fluorophores encapsulated in silica beads. J Phys Chem C 113:17669–1767710.1021/jp9044572 ↗
35. Mignot A, Truillet C, Lux F, Sancey L, Louis C, Denat F, Boschetti F, Bocher L, Gloter A, Stéphan O et al (2013) A top-down synthesis route to ultrasmall multifunctional Gd-based silica nanoparticles for theranostic applications. Chemistry 19:6122–613610.1002/chem.201203003 ↗
36. Munkholm C, Parkinson DR, Walt DR (1990) Intramolecular fluorescence self-quenching of fluoresceinamine. J Am Chem Soc 112:2608–261210.1021/ja00163a021 ↗
37. Mura S, Hillaireau H, Nicolas J, Le Droumaguet B, Gueutin C, Zanna S, Tsapis N, Fattal E (2011) Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomed 6:2591–2605
38. Musyanovych A, Dausend J, Dass M, Walther P, Mailänder V, Landfester K (2011) Criteria impacting the cellular uptake of nanoparticles: a study emphasizing polymer type and surfactant effects. Acta Biomater 7:4160–416810.1016/j.actbio.2011.07.033 ↗
39. Nabeshi H, Yoshikawa T, Arimori A, Yoshida T, Tochigi S, Hirai T, Akase T, Nagano K, Abe Y, Kamada H et al (2011) Effect of surface properties of silica nanoparticles on their cytotoxicity and cellular distribution in murine macrophages. Nanoscale Res Lett 6:9310.1186/1556-276X-6-93 ↗
40. Napierska D, Thomassen LC, Lison D, Martens JA, Hoet PH (2010) The nanosilica hazard: another variable entity. Part Fibre Toxicol 7:3910.1186/1743-8977-7-39 ↗
41. Nuutila J, Lilius E-M (2005) Flow cytometric quantitative determination of ingestion by phagocytes needs the distinguishing of overlapping populations of binding and ingesting cells. Cytometry A 65:93–10210.1002/cyto.a.20139 ↗
42. Ohkuma S, Poole B (1978) Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A 75:3327–333110.1073/pnas.75.7.3327 ↗
43. Panas A, Marquardt C, Nalcaci O, Bockhorn H, Baumann W, Paur H-R, Mülhopt S, Diabaté S, Weiss C (2013) Screening of different metal oxide nanoparticles reveals selective toxicity and inflammatory potential of silica nanoparticles in lung epithelial cells and macrophages. Nanotoxicology 7:259–27310.3109/17435390.2011.652206 ↗
44. Qiu Y, Liu Y, Wang L, Xu L, Bai R, Ji Y, Wu X, Zhao Y, Li Y, Chen C (2010) Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31:7606–761910.1016/j.biomaterials.2010.06.051 ↗
45. Rancan F, Gao Q, Graf C, Troppens S, Hadam S, Hackbarth S, Kembuan C, Blume-Peytavi U, Rühl E, Lademann J et al (2012) Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability. ACS Nano 6:6829–684210.1021/nn301622h ↗
46. Riehemann K, Schneider SW, Luger TA, Godin B, Ferrari M, Fuchs H (2009) Nanomedicine–challenge and perspectives. Angew Chem Int Ed Engl 48:872–89710.1002/anie.200802585 ↗
47. Seaton A, Donaldson K (2005) Nanoscience, nanotoxicology, and the need to think small. Lancet 365:923–92410.1016/S0140-6736(05)71061-8 ↗
48. Slowing II, Vivero-Escoto JL, Wu C-W, Lin VS-Y (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60:1278–128810.1016/j.addr.2008.03.012 ↗
49. Sohaebuddin SK, Thevenot PT, Baker D, Eaton JW, Tang L (2010) Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol 7:2210.1186/1743-8977-7-22 ↗
50. Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, Schlenk F, Fischer D, Kiouptsi K, Reinhardt C et al (2013) Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 8:772–78110.1038/nnano.2013.181 ↗
51. Vallet-Regi M, Balas F (2008) Silica materials for medical applications. Open Biomed Eng J 2:1–910.2174/1874120700802010001 ↗
52. Van Amersfoort ES, Van Strijp JA (1994) Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 17:294–30110.1002/cyto.990170404 ↗
53. Walkey CD, Chan WCW (2012) Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 41:2780–279910.1039/C1CS15233E ↗
54. Walkey CD, Olsen JB, Guo H, Emili A, Chan WCW (2012) Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134:2139–214710.1021/ja2084338 ↗
55. Yu T, Malugin A, Ghandehari H (2011) Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 5:5717–572810.1021/nn2013904 ↗
56. Yue Z-G, Wei W, Lv P-P, Yue H, Wang L-Y, Su Z-G, Ma G-H (2011) Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 12:2440–244610.1021/bm101482r ↗